Sino-Singapore Jingwei, May 29th,Zhongtong Bus(13.45 +8.14%,diagnostic stock), whose stock price has risen for 11 consecutive trading days, announced that the company's products are mainly passenger cars, and the number of nucleic acid testing medical special vehicles is currently relatively small. There was no significant impact on the company's operating performance.
On May 29, Zhongtong Bus issued an announcement on abnormal fluctuations instock trading. From May 13 to 27, the company's stock rose by the limit for 11 consecutive trading days.
Zhongtong Bus stated that there is no information that needs to be corrected or supplemented in the information disclosed by the company in the early stage.
In response to recent media reports on the company's nucleic acid testing medical vehicles, Zhongtong Bus said that the company's products are mainly passenger cars, and the current sales of nucleic acid testing medical vehicles are relatively small, which has not had a significant impact on the company's operating performance.In addition, the company has not found any undisclosed material information recently reported by public media that may or have had a significant impact on the company's stock trading price;
Zhongtong Bus also stated that the company's recent production and operation conditions are normal, and the internal and external operating environment has not occurred and is not expected to undergo major changes; after verification, the company, controlling shareholders and actual controllers have no material that should be disclosed but not disclosed. There is no major event in the planning stage; after verification, the company, the controlling shareholder and the actual controller did not buy or sell the company's stock during the abnormal fluctuation of the company's stock transaction.After self-examination, the company did not violate the fair disclosure of information disclosure.
Previously, the continuous rise in the share price of Zhongtong Bushas attracted the attention of the Shenzhen Stock Exchange.After the market close on May 27, Zhongtong Bus received a letter of concern from the Shenzhen Stock Exchange, asking to confirm whether there is any material information that should be disclosed but not disclosed, whether the company's fundamentals have undergone major changes, and considering the major risks faced by the company's production and operation recently and the stock price trend , valuation changes, etc., and provide adequate risk warnings for abnormal fluctuations in the company's stock price.
The letter of concern also pointed out that recently, there has been content related to the company's nucleic acid detection vehicle business on the interactive platform.
On May 10, Zhongtong Bus stated on the investor interaction platform that the company currently has two medical vehicles that can be used for nucleic acid testing.At present, the company's products sold in batches include two nucleic acid detection vehicles of 12 meters and 13 meters, all of which meet the P2+biosafetylaboratory standard, equipped with medical-specific air conditioning systems, equipped with high-efficiency fresh air filtration systems, medical water supply and drainage systems, and automatic PCR analysis. system,5Gsignal transmission, etc., with the functions of on-the-fly acquisition, on-the-fly inspection, and on-the-fly reporting.
Source: Shenzhen Stock Exchange Interactive Easy
The letter of concern requires that the business scale of the company's nucleic acid detection vehicle and its impact on the company's business development and profitability; list and analyze the composition of the company's main products from 2022 to the present, and indicate whether the company has recently introduced industry policies that have a significant impact on the company.
In terms of operating performance, in the first quarter of 2022, Zhongtong Bus achieved an operating income of 863 million yuan, a year-on-year increase of 30.93%; a net loss of 35.287 million yuan.In 2021, the operating income will be 4.587 billion yuan, a year-on-year increase of 4.06%; the net loss will be 220 million yuan, a record low profit since its listing.
In terms of the secondary market, on May 27, Zhongtong Bus hit the daily limit again, out of 11 consecutive boards, at 12.41 yuan per share, with a turnover of over 700 million yuan.It has risen by 185.94% in 11 trading days.(Sino-Singapore Jingwei APP)
